Wet Age Related Macular Degeneration Market Global Analysis 2017 Wet Age Related Macular Degeneration Market | Page 2

Wet Age Related Macular Degeneration Industry: Global Trend, Profit, and
Key Manufacturers Analysis Report
Wet AMD market is set to experience favourable growth driven by factors such as increasing elderly
population & rising health care expenditure. Further, the scope of growth for this market will be broadened
by increasing obese population and global economic development. However, growth of this budding
market will be hindered by lack of trained ophthalmologists, high cost of wet AMD drugs and associated
high risk.
Company Coverage of Global Wet Age Related Macular Degeneration Market: Regeneron
Pharmaceuticals, Inc., Novartis International AG, Roche Holding AG, and Bayer Group.
“Global Wet AMD market: Industry Analysis & Outlook (2017-2021)” analyses the development of this
market, with focus on the U.S. and outside the U.S. markets. The major trends, growth drivers as well as
issues being faced by the market are discussed in detail in this report. The four major players: Regeneron
Pharmaceuticals, Inc. Novartis International AG, Roche Holding AG & Bayer Group are being profiled along
with their key financials and strategies for growth. The report contains a comprehensive analysis of the
global wet AMD market along with the study of the regional markets
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision that people need
for “straight-ahead” activities such as reading, sewing, and driving. In some people, AMD advances so
slowly that vision loss does not occur for a long time. In others, the disease progresses faster and may lead
to a loss of vision in one or both eyes. As AMD progresses, a blurred area near the center of vision is a
common symptom. Over time, the blurred area may grow larger or it may develop blank spots in central
vision.
Complete report available at http://www.marketreportsonline.com/584683.html